Device Week, 4 February 2021 – SPACs In Medtech; Manus’ Parkinson’s Pen; TAVR During COVID

Citeline Podcasts

English - February 04, 2021 21:27 - 11 minutes - 20.4 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Top Medical Device Lobbyist On User Fee Talks, Biden And New Congress, Implementing MCIT Rule

Next Episode: Pink Sheet Podcast: COVID-19 variants and vaccine trial dropouts, Aducanumab, User Fee Goal Changes

This week’s podcast includes an update on the growing trend of “blank check” companies taking medtech companies public, a spotlight on Manus’ pen that can diagnose Parkinson’s disease, and a look at how pandemic is impacting valve replacements.

Medtech Insight articles addressing topics in this episode:
Blank Check Companies’ Hunt For Innovative Medtech Start-Ups To Heat Up Further, Experts Predict
http://bit.ly/2YIxqIn

Start-Up Spotlight: Manus Neurodynamica Hopes To Write The End Of Traditional Parkinson’s Diagnosis
http://bit.ly/3aA7VOP

Edwards Keeps TAVR Going During COVID-19 Surge
http://bit.ly/3cIyJiK